Efeitos do uso do acetato de leuprolide nas caraterísticas reprodutivas de roedores submetidos ao tratamento com testosterona propionato pré e pós-natal

Detalhes bibliográficos
Autor(a) principal: Mujica, Lady Katerine Serrano
Data de Publicação: 2016
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Manancial - Repositório Digital da UFSM
Texto Completo: http://repositorio.ufsm.br/handle/1/17655
Resumo: Androgen excess induces in female rats reproductive and metabolic disturbances that are similar to polycystic ovary syndrome in women. In these animals, the degree of changes may vary according to the timeline intervention, suggesting that the hypothalamic and pituitary axis may present different actions at pituitary-hypothalamic level before and after birth. The present study employed an agonist GnRH, leuprolide acetate, administrated as a single dose upto 48h of life in Wistar rats under prenatal or postnatal androgenisation protocols, looking for its effects on reproductive endpoints. Prenatal androgenisation (PreN) consisted in the administration of testosterone propionate 2.5 mg s.c. to mothers at the days 16,17 and 18, while postnatal androgenisation (PostN) was performed through the injection of 1.25 mg s.c. to animals within 5 day of life. Between 90 - 100 days of life, these rats were evaluated to the present of estral cycles (defined by vaginal smears and the presence of corpus luteum (CL), steroid levels (serum testosterone and androstenedione measured by liquid chromatography (HLPC MS/MS), ovarian morphology (histology), and the expression of mRNA for hypothalamic Kiss1, Gnrhr, and Gnrh and ovarian genes (Cyp17a1, Cyp19a1, CYp11a1,and Gnrhr).We observed that in PostN group, characterized by anovulation and increased number of cysts/atretic follicles), a single injection of a leuprolide acetate depot (lasting 4 weeks) (PostN L)was able to increase ovulatory rates, as defined by vaginal smears. The treatment with this GnRH agonist in PostN L also reduced testosterone serum levels as well the number of cysts/atretic follicles in contrast with PostN group (p=0.04). Prenatally androgenized rats (PreN) exhibited significant abnormalities at hypothalamic genes, such as a reduction of Kiss1 and increased of Gnrh,in comparison with control and PostM groups. To the best of our knowledge, this is the first study to show that previous administration of a single dose of GnRH agonist (leuprolide acetate) could successfully preserve regular cycles, reduce androgen levels and the number of cysts/atretic follicles in rats submitted to androgen excess postnatally. Indeed, the results obtained with this model of PCOS suggest a clear participation of GnRH disruption to the progress to anovulation and cysts development.
id UFSM_cb907e141ac844f9a9f4f64b759e4058
oai_identifier_str oai:repositorio.ufsm.br:1/17655
network_acronym_str UFSM
network_name_str Manancial - Repositório Digital da UFSM
repository_id_str
spelling Efeitos do uso do acetato de leuprolide nas caraterísticas reprodutivas de roedores submetidos ao tratamento com testosterona propionato pré e pós-natalThe impact of postnatal leuprolide acetate treatment on reproductive characteristics in a rodent model of polycystic ovary syndromeSíndrome do ovário policísticoProgramação de desenvolvimentoAcetato de leuprolidePolycystic ovary syndromeDevelopmental programmingLeuprolide acetateCNPQ::CIENCIAS DA SAUDE::FARMACIAAndrogen excess induces in female rats reproductive and metabolic disturbances that are similar to polycystic ovary syndrome in women. In these animals, the degree of changes may vary according to the timeline intervention, suggesting that the hypothalamic and pituitary axis may present different actions at pituitary-hypothalamic level before and after birth. The present study employed an agonist GnRH, leuprolide acetate, administrated as a single dose upto 48h of life in Wistar rats under prenatal or postnatal androgenisation protocols, looking for its effects on reproductive endpoints. Prenatal androgenisation (PreN) consisted in the administration of testosterone propionate 2.5 mg s.c. to mothers at the days 16,17 and 18, while postnatal androgenisation (PostN) was performed through the injection of 1.25 mg s.c. to animals within 5 day of life. Between 90 - 100 days of life, these rats were evaluated to the present of estral cycles (defined by vaginal smears and the presence of corpus luteum (CL), steroid levels (serum testosterone and androstenedione measured by liquid chromatography (HLPC MS/MS), ovarian morphology (histology), and the expression of mRNA for hypothalamic Kiss1, Gnrhr, and Gnrh and ovarian genes (Cyp17a1, Cyp19a1, CYp11a1,and Gnrhr).We observed that in PostN group, characterized by anovulation and increased number of cysts/atretic follicles), a single injection of a leuprolide acetate depot (lasting 4 weeks) (PostN L)was able to increase ovulatory rates, as defined by vaginal smears. The treatment with this GnRH agonist in PostN L also reduced testosterone serum levels as well the number of cysts/atretic follicles in contrast with PostN group (p=0.04). Prenatally androgenized rats (PreN) exhibited significant abnormalities at hypothalamic genes, such as a reduction of Kiss1 and increased of Gnrh,in comparison with control and PostM groups. To the best of our knowledge, this is the first study to show that previous administration of a single dose of GnRH agonist (leuprolide acetate) could successfully preserve regular cycles, reduce androgen levels and the number of cysts/atretic follicles in rats submitted to androgen excess postnatally. Indeed, the results obtained with this model of PCOS suggest a clear participation of GnRH disruption to the progress to anovulation and cysts development.A exposição a uma grande quantidade de androgênios pode induzir perturbações na função reprodutiva e metabólica em ratas fêmeas que se assemelham a síndrome dos ovários policísticos (SOP) em mulheres. Nestes animais, o grau de alteração na esteroidogênese e foliculogênese pode variar de acordo com o período de intervenção, o que sugere diferentes mecanismos de atuação no eixo hipotalâmico-pituitário, antes e após o nascimento. Neste estudo, utilizou-se um agonista de GnRH, acetato de leuprolide, administrado por uma única injeção de depósito até 48h de vida em ratas Wistar submetidos ao pré-natal e pós-natal protocolos androgenização à procura de seu impacto reprodutivos. Androgenização pré-natal consistiu na administração de 2,5 mg de testosterona propionato s.c. às mães nos dias 16, 17 e 18 (grupo pré-natal ou PreN), enquanto androgenização pós-natal foi realizada através da injeção de 1,25 mg de testosterona propionato s.c aos animais em 5 dias de vida (Grupo pós-natal ou PostN). Entre 90 e 110 dias de vida, estes animais foram avaliados para os ciclos de estro (definida por citologia de série vaginal e a presença do corpo lúteo), a produção de esteroides (níveis séricos de testosterona e androstenediona medida por HPLC-MS / MS), morfologia dos ovários (histologia) e da expressão gênica hipotalâmica de Kiss1, Gnrhr e GnRH. Observamos que no grupo PostN, caracterizado por anovulação e aumento do número combinado de cistos e folículos atrésicos, que uma única injeção de acetato de leuprolide depot (usualmente com duração de quatro semanas) foi capaz de aumentar no animal adulto as taxas de ovulação estimadas por esfregaço vaginal. O tratamento com este agonista do GnRH também reduziu os níveis de testosterona no soro e o número de cistos e folículos atréticos em PostN L em contraste com os animais do grupo PostN (p = 0,04), ratos pré-natal androgenizadas (PreN) exibiram alterações significativas nos genes hipotalâmicos, tais como uma redução de Kiss1 e aumento da Gnrh, em comparação com grupos de controle e PostN. Em nosso conhecimento, este é o primeiro estudo a mostrar que a administração de agonista de GnRH (acetato de leuprolide) em dose única pode preservar com sucesso ciclos regulares, reduzir os níveis de androgênios e o número de cistos / folículos atrésicos em ratas após o nascimento androgenizadas. Além disso, os resultados obtidos neste modelo animal de SOP sugerem uma clara participação de anormalidades no GnRH levando a anovulação e formação de cistos.Universidade Federal de Santa MariaBrasilFarmacologiaUFSMPrograma de Pós-Graduação em FarmacologiaCentro de Ciências da SaúdeComim, Fabio Vasconcelloshttp://lattes.cnpq.br/5119233991388822Premaor, Melissa Orlandinhttp://lattes.cnpq.br/1919693261808995Capp, Edisonhttp://lattes.cnpq.br/8402261714372726Mello, Carlos Fernando dehttp://lattes.cnpq.br/3913887223894236Mujica, Lady Katerine Serrano2019-07-31T20:36:10Z2019-07-31T20:36:10Z2016-07-30info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttp://repositorio.ufsm.br/handle/1/17655porAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessreponame:Manancial - Repositório Digital da UFSMinstname:Universidade Federal de Santa Maria (UFSM)instacron:UFSM2019-08-01T06:01:25Zoai:repositorio.ufsm.br:1/17655Biblioteca Digital de Teses e Dissertaçõeshttps://repositorio.ufsm.br/ONGhttps://repositorio.ufsm.br/oai/requestatendimento.sib@ufsm.br||tedebc@gmail.comopendoar:2019-08-01T06:01:25Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM)false
dc.title.none.fl_str_mv Efeitos do uso do acetato de leuprolide nas caraterísticas reprodutivas de roedores submetidos ao tratamento com testosterona propionato pré e pós-natal
The impact of postnatal leuprolide acetate treatment on reproductive characteristics in a rodent model of polycystic ovary syndrome
title Efeitos do uso do acetato de leuprolide nas caraterísticas reprodutivas de roedores submetidos ao tratamento com testosterona propionato pré e pós-natal
spellingShingle Efeitos do uso do acetato de leuprolide nas caraterísticas reprodutivas de roedores submetidos ao tratamento com testosterona propionato pré e pós-natal
Mujica, Lady Katerine Serrano
Síndrome do ovário policístico
Programação de desenvolvimento
Acetato de leuprolide
Polycystic ovary syndrome
Developmental programming
Leuprolide acetate
CNPQ::CIENCIAS DA SAUDE::FARMACIA
title_short Efeitos do uso do acetato de leuprolide nas caraterísticas reprodutivas de roedores submetidos ao tratamento com testosterona propionato pré e pós-natal
title_full Efeitos do uso do acetato de leuprolide nas caraterísticas reprodutivas de roedores submetidos ao tratamento com testosterona propionato pré e pós-natal
title_fullStr Efeitos do uso do acetato de leuprolide nas caraterísticas reprodutivas de roedores submetidos ao tratamento com testosterona propionato pré e pós-natal
title_full_unstemmed Efeitos do uso do acetato de leuprolide nas caraterísticas reprodutivas de roedores submetidos ao tratamento com testosterona propionato pré e pós-natal
title_sort Efeitos do uso do acetato de leuprolide nas caraterísticas reprodutivas de roedores submetidos ao tratamento com testosterona propionato pré e pós-natal
author Mujica, Lady Katerine Serrano
author_facet Mujica, Lady Katerine Serrano
author_role author
dc.contributor.none.fl_str_mv Comim, Fabio Vasconcellos
http://lattes.cnpq.br/5119233991388822
Premaor, Melissa Orlandin
http://lattes.cnpq.br/1919693261808995
Capp, Edison
http://lattes.cnpq.br/8402261714372726
Mello, Carlos Fernando de
http://lattes.cnpq.br/3913887223894236
dc.contributor.author.fl_str_mv Mujica, Lady Katerine Serrano
dc.subject.por.fl_str_mv Síndrome do ovário policístico
Programação de desenvolvimento
Acetato de leuprolide
Polycystic ovary syndrome
Developmental programming
Leuprolide acetate
CNPQ::CIENCIAS DA SAUDE::FARMACIA
topic Síndrome do ovário policístico
Programação de desenvolvimento
Acetato de leuprolide
Polycystic ovary syndrome
Developmental programming
Leuprolide acetate
CNPQ::CIENCIAS DA SAUDE::FARMACIA
description Androgen excess induces in female rats reproductive and metabolic disturbances that are similar to polycystic ovary syndrome in women. In these animals, the degree of changes may vary according to the timeline intervention, suggesting that the hypothalamic and pituitary axis may present different actions at pituitary-hypothalamic level before and after birth. The present study employed an agonist GnRH, leuprolide acetate, administrated as a single dose upto 48h of life in Wistar rats under prenatal or postnatal androgenisation protocols, looking for its effects on reproductive endpoints. Prenatal androgenisation (PreN) consisted in the administration of testosterone propionate 2.5 mg s.c. to mothers at the days 16,17 and 18, while postnatal androgenisation (PostN) was performed through the injection of 1.25 mg s.c. to animals within 5 day of life. Between 90 - 100 days of life, these rats were evaluated to the present of estral cycles (defined by vaginal smears and the presence of corpus luteum (CL), steroid levels (serum testosterone and androstenedione measured by liquid chromatography (HLPC MS/MS), ovarian morphology (histology), and the expression of mRNA for hypothalamic Kiss1, Gnrhr, and Gnrh and ovarian genes (Cyp17a1, Cyp19a1, CYp11a1,and Gnrhr).We observed that in PostN group, characterized by anovulation and increased number of cysts/atretic follicles), a single injection of a leuprolide acetate depot (lasting 4 weeks) (PostN L)was able to increase ovulatory rates, as defined by vaginal smears. The treatment with this GnRH agonist in PostN L also reduced testosterone serum levels as well the number of cysts/atretic follicles in contrast with PostN group (p=0.04). Prenatally androgenized rats (PreN) exhibited significant abnormalities at hypothalamic genes, such as a reduction of Kiss1 and increased of Gnrh,in comparison with control and PostM groups. To the best of our knowledge, this is the first study to show that previous administration of a single dose of GnRH agonist (leuprolide acetate) could successfully preserve regular cycles, reduce androgen levels and the number of cysts/atretic follicles in rats submitted to androgen excess postnatally. Indeed, the results obtained with this model of PCOS suggest a clear participation of GnRH disruption to the progress to anovulation and cysts development.
publishDate 2016
dc.date.none.fl_str_mv 2016-07-30
2019-07-31T20:36:10Z
2019-07-31T20:36:10Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://repositorio.ufsm.br/handle/1/17655
url http://repositorio.ufsm.br/handle/1/17655
dc.language.iso.fl_str_mv por
language por
dc.rights.driver.fl_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade Federal de Santa Maria
Brasil
Farmacologia
UFSM
Programa de Pós-Graduação em Farmacologia
Centro de Ciências da Saúde
publisher.none.fl_str_mv Universidade Federal de Santa Maria
Brasil
Farmacologia
UFSM
Programa de Pós-Graduação em Farmacologia
Centro de Ciências da Saúde
dc.source.none.fl_str_mv reponame:Manancial - Repositório Digital da UFSM
instname:Universidade Federal de Santa Maria (UFSM)
instacron:UFSM
instname_str Universidade Federal de Santa Maria (UFSM)
instacron_str UFSM
institution UFSM
reponame_str Manancial - Repositório Digital da UFSM
collection Manancial - Repositório Digital da UFSM
repository.name.fl_str_mv Manancial - Repositório Digital da UFSM - Universidade Federal de Santa Maria (UFSM)
repository.mail.fl_str_mv atendimento.sib@ufsm.br||tedebc@gmail.com
_version_ 1805922088591032320